Apixaban for stroke prevention in atrial fibrillation: why are event rates higher in clinical practice than in randomized trials?—a systematic review
TAC de Vries, J Hirsh, K Xu, I Mallick… - Thrombosis and …, 2020 - thieme-connect.com
Background Recent reports suggest an important contribution from frequent off-label use of
apixaban 2.5 mg twice daily to the higher rates of thromboembolic events observed in …
apixaban 2.5 mg twice daily to the higher rates of thromboembolic events observed in …
Effectiveness and safety of apixaban in over 3.9 million people with atrial fibrillation: a systematic review and meta-analysis
BJR Buckley, DA Lane, P Calvert, J Zhang… - Journal of clinical …, 2022 - mdpi.com
Background: There is a plethora of real-world data on the safety and effectiveness of direct-
acting oral anticoagulants (DOACs); however, study heterogeneity has contributed to …
acting oral anticoagulants (DOACs); however, study heterogeneity has contributed to …
Non-vitamin K antagonist oral anticoagulants and the gastrointestinal bleeding risk in real-world studies
In the present study, we aimed to provide evidence from high-quality real world studies for a
comprehensive and rigorous analysis on the gastrointestinal bleeding (GIB) risk for non …
comprehensive and rigorous analysis on the gastrointestinal bleeding (GIB) risk for non …
[HTML][HTML] Patrones y resultados del cambio de anticoagulantes orales directos en la fibrilación auricular no valvular: experiencia en la práctica clínica en España
E Rodilla, MI Orts-Martínez, MÁ Sanz-Caballer… - Revista Clínica …, 2023 - Elsevier
Objetivos El objetivo consistía en evaluar un programa de gestión de anticoagulantes orales
directos (ACOD) en pacientes con fibrilación auricular no valvular (FANV) según sus …
directos (ACOD) en pacientes con fibrilación auricular no valvular (FANV) según sus …
Patterns and outcomes of switching direct oral anticoagulants in non-valvular atrial fibrillation: A real-world experience from Spain
E Rodilla, MI Orts-Martínez, MA Sanz-Caballer… - Revista Clínica …, 2023 - Elsevier
Aims The aim is to evaluate a management program for direct oral anticoagulants (DOACs)
in non-valvular atrial fibrillation (NVAF) patients according to their profiles, appropriateness …
in non-valvular atrial fibrillation (NVAF) patients according to their profiles, appropriateness …
[HTML][HTML] Influence of the COVID-19 pandemic on patients receiving oral anticoagulants for the treatment of non-valvular atrial fibrillation
JC Colet, AS Mainar, J Salazar-Mendiguchía… - IJC Heart & …, 2024 - Elsevier
Background Frequent monitoring of patients declined during the COVID-19 pandemic,
harming patients with chronic diseases who critically needed correct monitoring. We …
harming patients with chronic diseases who critically needed correct monitoring. We …
Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol
JC Colet, AS Mainar… - Journal of …, 2023 - becarispublishing.com
Aim: Healthcare resources usage and costs associated to nonvalvular atrial fibrillation
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …
(NVAF) were analyzed in Spain. Methods: This is an observational and retrospective study …
Characteristics and management of patients with stroke and major hemorrhagic episodes with atrial fibrillation under vitamin K antagonist therapy. EVENTHO study
O Gavin, V Roldan, P Llamas-Sillero, A Santamaria… - Medicina Clínica, 2022 - Elsevier
Abstract Introduction and objective In Spain, vitamin K antagonists (VKA) remain the
standard treatment for the prevention of thromboembolic and hemorrhagic complications in …
standard treatment for the prevention of thromboembolic and hemorrhagic complications in …
Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Real-World Experience from a Single Spanish Regional Hospital
E Rodilla, MI Orts-Martinez, MA Sanz-Caballer… - 2021 - preprints.org
The aim is to evaluate a program for direct oral anticoagulants (DOACs) management in
nonvalvular atrial fibrillation (NVAF) patients, according to patient profiles, appropriateness …
nonvalvular atrial fibrillation (NVAF) patients, according to patient profiles, appropriateness …